HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Specific inhibition of the Akt1 pleckstrin homology domain by D-3-deoxy-phosphatidyl-myo-inositol analogues.

Abstract
Activation of Akt (protein kinase B), a Ser/Thr protein kinase that promotes cell survival, has been linked to tumorigenesis. Akt is activated by phosphorylation after binding of its pleckstrin homology (PH) domain to plasma membrane phosphatidyl-myo-inositol-3-phosphates, formed by phosphoinositide-3-kinase. We report a novel strategy to inhibit Akt activation based on the use of D-3-deoxy-phosphatidyl-myo-inositols (DPIs) that cannot be phosphorylated on the 3-position of the myo-inositol ring. We have studied the DPIs, DPI 1-[(R)-2,3-bis(hexadecanoyloxy)propyl hydrogen phosphate], its ether lipid derivative DPI 1-[(R)-2-methoxy-3-octadecyloxypropyl hydrogen phosphate] (DPIEL), and its carbonate derivative DPI 1-[(R)-2-methoxy-3-octadecyloxypropyl carbonate]. We demonstrate in platelet-derived growth factor-stimulated mouse NIH3T3 cells that the DPIs bind to the PH domain of Akt, trapping it in the cytoplasm and thus preventing Akt activation. DPIEL did not inhibit myristylated-Akt, a constitutively active membrane-bound Akt expressed in NIH3T3 cells, and cell growth was not inhibited, unlike in wild-type NIH3T3 cells. Molecular modeling and docking studies show that DPIEL binds with much higher affinity to Akt's PH domain as compared with DPI and DPI 1-[(R)-2-methoxy-3-octadecyloxypropyl carbonate]. This study shows that the DPIs are a novel class of growth inhibitory agents with a novel mechanism of action through binding to the PH domain of Akt and inhibition of Akt activation.
AuthorsEmmanuelle J Meuillet, Daruka Mahadevan, Hariprasad Vankayalapati, Margareta Berggren, Ryan Williams, Amy Coon, Alan P Kozikowski, Garth Powis
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 2 Issue 4 Pg. 389-99 (Apr 2003) ISSN: 1535-7163 [Print] United States
PMID12700283 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Blood Proteins
  • Enzyme Inhibitors
  • Myristic Acids
  • Phosphatidylinositols
  • Phosphoproteins
  • Proto-Oncogene Proteins
  • platelet protein P47
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
Topics
  • Animals
  • Apoptosis
  • Binding Sites
  • Blood Proteins (chemistry)
  • Cell Division
  • Cell Line, Tumor
  • Cell Membrane (metabolism)
  • Dose-Response Relationship, Drug
  • Enzyme Activation
  • Enzyme Inhibitors (pharmacology)
  • Lipid Metabolism
  • Mice
  • Models, Biological
  • Models, Chemical
  • Models, Molecular
  • Myristic Acids (metabolism)
  • NIH 3T3 Cells
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphatidylinositols (chemistry, pharmacology)
  • Phosphoproteins (chemistry)
  • Phosphorylation
  • Protein Binding
  • Protein Serine-Threonine Kinases (antagonists & inhibitors, chemistry)
  • Protein Structure, Tertiary
  • Protein Transport
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-akt
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: